The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Novartis Pharmaceuticals Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
- 2025 (7)
- 2024 (20)
- 2023 (44)
- 2022 (38)
- 2021 (36)
- 2020 (58)
- 2019 (31)
- 2018 (47)
- 2017 (11)
- 2016 (44)
- 2015 (37)
- 2014 (10)
- 2013 (12)
- 2012 (6)
- 2011 (6)
- 2010 (28)
- 2009 (4)
- 2008 (15)
- 2007 (1)
- 2006 (4)
- 2005 (11)
- 2004 (4)
- 2003 (5)
- 2002 (7)
- 2001 (5)
- 2000 (8)
- 1999 (2)
- 1998 (2)
- 1997 (4)
- 1996 (4)
- 1995 (4)
- 1993 (10)
- 1992 (3)
- 1991 (16)
Sponsor content
544 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Novartis Pharmaceuticals Australia Pty Ltd - Prefilled syringe/needle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LIORESAL 10 baclofen 10mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag.
-
Designation or determinationOrphan drug
-
Designation or determinationPriority review
-
Prescription medicine registrationActive ingredients: Canakinumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Novartis Pharmaceuticals Australia Pty Ltd - Surgical procedure kit, ophthalmic, medicated, single-use.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SIMULECT basiliximab (rmc) 20mg powder for injection vial.
-
Cancellation by sponsorRequested by Novartis Pharmaceuticals Australia Pty Ltd